Chemoinformaics analysis of N-Methylbenzylamine
Molecular Weight | 121.183 | nRot | 2 |
Heavy Atom Molecular Weight | 110.095 | nRig | 6 |
Exact Molecular Weight | 121.089 | nRing | 1 |
Solubility: LogS | 0.386 | nHRing | 0 |
Solubility: LogP | 1.534 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 1 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 21.7947 |
nHD | 1 | BPOL | 11.6053 |
QED | 0.623 |
Synth | 1.271 |
Natural Product Likeliness | -0.19 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.352 |
MDCK | 0.0000359 |
BBB | 0.76 |
PPB | 0.14795 |
VDSS | 3.713 |
FU | 0.658268 |
CYP1A2-inh | 0.394 |
CYP1A2-sub | 0.489 |
CYP2c19-inh | 0.064 |
CYP2c19-sub | 0.874 |
CYP2c9-inh | 0.005 |
CYP2c9-sub | 0.164 |
CYP2d6-inh | 0.538 |
CYP2d6-sub | 0.877 |
CYP3a4-inh | 0.034 |
CYP3a4-sub | 0.225 |
CL | 10.281 |
T12 | 0.764 |
hERG | 0.117 |
Ames | 0.03 |
ROA | 0.87 |
SkinSen | 0.651 |
Carcinogencity | 0.058 |
EI | 0.341 |
Respiratory | 0.95 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.916637 |